Large-scale testing (Phase 3)Looking for participantsNCT05491525
What this trial is testing
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Who this might be right for
Neurogenic Detrusor Overactivity
Urovant Sciences GmbH 71